Weight Loss Composition

A dry weight loss composition suitable for ingestion by an obese subject, said composition comprising a particle admixture of:

• at least one exogenous amino acid precursor able to utilized in a catecholamine biosynthesis pathway;
• at least one exogenous sympathomimetic agent able to stimulate the sympathetic nervous system;
• and
• a lipolytic agent;
• and
• a high-Dalton macromolecular protein.

A dry weight loss composition suitable for ingestion by an obese subject, said composition comprising a particle admixture of:

• at least one exogenous amino acid precursor able to utilized in a catecholamine biosynthesis pathway;
• at least one exogenous sympathomimetic agent able to stimulate the sympathetic nervous system;
• and
• a lipolytic agent;
• a high-Dalton macromolecular protein;
• and
• at least one micronutrient.

A fluid weight loss composition suitable for ingestion by an obese subject, said composition comprising:

• at least one exogenous amino acid precursor able to be utilized in a catecholamine biosynthesis pathway;
• at least one exogenous sympathomimetic agent able to stimulate the sympathetic nervous system;
• at least one substance selected from the group consisting of a lipolytic agent and a high-Dalton macromolecular protein;
• and
• a liquid aqueous carrier.

A fluid weight loss composition suitable for ingestion by an obese subject, said composition comprising:

• at least one exogenous amino acid precursor able to be utilized in a catecholamine biosynthesis pathway;
• at least one exogenous sympathomimetic agent able to stimulate the sympathetic nervous system;
• and
• a lipolytic agent;
• a high-Dalton macromolecular protein;
• and
• a liquid aqueous carrier.

A fluid weight loss composition suitable for ingestion by an obese subject, said composition comprising:

• at least one exogenous amino acid precursor able to be utilized in a catecholamine biosynthesis pathway;
• at least one exogenous sympathomimetic agent able to stimulate the sympathetic nervous system;
• and
• a lipolytic agent;
• a high-Dalton macromolecular protein;
• at least one micronutrient;
• and
• a liquid aqueous carrier.

A method for producing a measurable weight loss in a living obese subject, said method comprising the steps of:

• obtaining a fluid weight loss composition comprising:
• (i) at least one exogenous amino acid precursor able to be utilized in a catecholamine biosynthesis pathway,
• (ii) at least one exogenous sympathomimetic agent able to stimulate the sympathetic nervous system,
• (iii) at least one substance selected from the group consisting of a lipolytic agent and a high-Dalton macromolecular protein, and
• (iv) a liquid aqueous carrier;
• orally administrating said fluid weight loss composition to the living individual subject on a scheduled basis and in predetermined dose quantities over a decided duration of time;
• allowing the orally administered fluid weight loss composition to induce a marked increase in the basal metabolic rate for the living individual subject over time;
• and
• permitting said induced increase in the basal metabolic rate for the living individual subject to cause a measurable weight loss for the living individual subject.

A method for producing a measurable weight loss in a living obese subject, said method comprising the steps of:

• obtaining a fluid weight loss composition comprising:
• (i) at least one exogenous amino acid precursor able to be utilized in a catecholamine biosynthesis pathway,
• (ii) at least one exogenous sympathomimetic agent able to stimulate the sympathetic nervous system,
• (iii) a lipolytic agent,
• (iv) a high-Dalton macromolecular protein, and
• (v) a liquid aqueous carrier;
• orally administrating said fluid weight loss composition to the living individual subject on a scheduled basis and in predetermined dose quantities over a
• decided duration of time;
• allowing the orally administered fluid weight loss composition to induce a marked increase in the basal metabolic rate for the living individual subject over time;
• and
• permitting said induced increase in the basal metabolic rate to cause a measurable weight loss for the living individual subject.

A method for producing a measurable weight loss in a living obese subject, said method comprising the steps of:

• obtaining a fluid weight loss composition comprising:
• (i) at least one exogenous amino acid precursor able to be utilized in a catecholamine biosynthesis pathway,
• (ii) at least one exogenous sympathomimetic agent able to stimulate the sympathetic nervous system,
• (iii) a lipolytic agent,
• (iv) a high-Dalton macromolecular protein,
• (v) at least one micronutrient, and
• (vi) a liquid aqueous carrier;
• orally administrating said fluid weight loss composition to the living individual subject on a scheduled basis and in predetermined dose quantities over a decided duration of time;
• allowing the orally administered fluid weight loss composition to induce a marked increase in the basal metabolic rate for the living individual subject over time;
• and
• permitting said induced increase in the basal metabolic rate to cause a measurable weight loss for the living individual subject.